Role of p21 and cyclin e in normal and secalonic acid d-inhibited proliferation of human embryonic palatal mesenchymal cells

Human and Experimental Toxicology

Volumn 30, Issue 9, 2011, Pages 1222-1232

  Dhulipala, Vamsidhara C ^a   Maddali, Kamala K ^a   Ray, Bimal K ^b   Welshons, Wade V ^b   Reddy, Chada S ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

cleft palate; cyclin E; human embryonic palatal mesenchymal cell; p21; proliferation; secalonic acid D

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN E; KI 67 ANTIGEN; PROTEIN P21; SECALONIC ACID D; SMALL INTERFERING RNA; THYMIDINE;

ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CLEFT PALATE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN EMBRYONIC PALATAL MESENCHYMAL CELL; HYPOTHESIS; MESENCHYME CELL; MITOSIS INHIBITION; PALATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SILENCER GENE; TERATOGENICITY; TRANSIENT TRANSFECTION; UPREGULATION;

CELL CULTURE TECHNIQUES; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE SILENCING; HUMANS; IMMUNOBLOTTING; MESODERM; PALATE; RNA, SMALL INTERFERING; XANTHONES;

EID: 80052544319     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110387238     Document Type: Article

References (37)

1. Reddy CS, Reddy RV, Hayes AW, Ciegler A. Teratogenicity of secalonic acid D in mice. J Toxicol Environ Health. 1981 ; 7: 445-445
2. Abbott BD, Buckalew AR. Embryonic palatal responses to teratogens in serum-free organ culture. Teratology. 1992 ; 45: 369-369
3. Huang HZ, Lu BH, Chen YY, Liao GQ. Study on etiology of retinoic acid-induced cleft palate in mouse. Zhonghua Kou Qiang Yi Xue Za Zhi. 2003 ; 38: 185-185
4. Johnson DG, Walker CL. Cyclins and cell cycle check points. Ann Rev Pharmacol Toxicol. 1999 ; 39: 295-295
5. Sherr CJ. Cancer cell cycles (Review). Science. 1996 ; 274: 1672-1672
6. Yam CH, Fung TK, Poon RY. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci. 2002 ; 59: 1317-1317
7. Ehrlich KC, Lee LS, Ciegler A, Palmgren MS. Secalonic acid D: natural contaminant of corn dust. Appl Environ Microbiol. 1982 ; 44: 1007-1008 (Pubitemid 13213377)
8. Steyn PS. The isolation, structure and absolute configuration of secalonic acid D, the toxic metabolite of Penicillium oxalicum. Tetrahedron. 1970 ; 26: 51-51
9. Eldeib MM, Reddy CS. Secalonic acid D-induced changes in palatal cyclic AMP and GMP in developing mice. Teratology. 1988 ; 37: 343-343
10. Hanumegowda UM, Judy BM, Welshons WV, Reddy CS. Selective inhibition of murine palatal mesenchymal cell proliferation in vitro by secalonic acid D. Toxicol Sci. 2002 ; 66: 159-159
11. Dhulipala VC, Welshons WV, Reddy CS. Inhibition of human embryonic palatal mesenchymal cell cycle by secalonic acid d: a probable mechanism of its cleft palate induction. Orthod Craniofac Res. 2004 ; 7: 1-1
12. Dhulipala VC, Maddali KK, Welshons WV, Reddy CS. Mechanism of inhibition of embryonic palatal mesenchymal cell cycle by secalonic acid D. Birth Def Res (Part B). 2005 ; 74: 233-233
13. McDonald GT, Sullivan R, Paré GC, Graham CH. Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression. Exp Cell Res. 2010 ;:
14. Kong L, Deng Z, Zhao Y, Wang Y, Sarkar FH, Zhang Y. Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells. Med Oncol. 2010 ;:
15. Balasubramanian G, Reddy CS. Novel mechanism of inhibition of protein kinase C involving pseudo substrate region by secalonic acid D. Toxicol Appl Pharmacol. 2000 ; 163: 86-86
16. Hanumegowda UM, Dhulipala VC, Reddy CS. Mechanism of Secalonic acid D-induced inhibition of transcription factor binding to cyclic AMP response element in developing murine secondary palate. Toxicol Sci. 2002 ; 70: 55-55
17. Chien MH, Lee TS, Liang YC, Lee WS. Beta-sitosterol inhibits cell cycle progression of rat aortic smooth muscle cells through increases of p21(cip1) protein. J Agri Food Chem. 2010 ;:
18. Liu J, Hu JL, Shi BW, He Y, Hu WX. Up-regulation of p21 and TNF-alpha is mediated in lycorine-induced death of HL-60 cells. Cancer Cell Int. 2010 ; 10: 25-25
19. Reddy CS, Hayes AW, Williams WL, Ciegler A. Toxicity of secalonic acid D in mice. J Toxicol Environ Health. 1979 ; 5: 1159-1159
20. Baghdassarian AP, Devaux E, Bryon PA, Ffrench M. Involvement of p27Kip1 in the G1-and S/G2- phase lengthening mediated by glucocorticoids in normal human lymphocytes. Cell Growth Differ. 1999 ; 10: 405-405
21. Bradford MM. A rapid and sensitive method for micrograms quantities of protein using the principles of protein dye binding. Anal Biochem. 1976 ; 15: 93-93
22. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000 ; 182: 311-311
23. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999 ; 13: 1501-1501
24. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995 ; 81: 323-323
25. Aikawa T, Segre GV, Lee K. Fibroblast growth factor inhibits chondrocyte growth through induction of p21 and subsequent inhibition of cyclin E-cdk2. J Biol Chem. 2001 ; 276: 29347-29347
26. Kim TJ, Han HJ, Lim Y, Song MC, Kim J, Hong JT, et al. Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling. J Cardiovasc Pharmacol. 2009 ; 53: 341-341
27. Ye M, Iu BC, Jia XW, Gao A, Jiao S, Zhang FM. [Effects of p53 in benzo (a) pyrene induced p21 and E2F-1 expression and cell cycle changes]. Zhonghua Yu Fang Yi Xue Za Zhi. 2008 ; 42: 400-400
28. Ahn MY, Lee J, Na YJ, Choi WS, Lee BM, Kang KW, et al. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells. Chem Biol Interact. 2009 ; 179: 169-169
29. Wolfraim LA, Walz TM, James Z, Fernandez T, Letterio JJ. p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness. J Immunol. 2004 ; 173: 3093-3093
30. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by myoD. Science. 1995 ; 267: 1018-1018
31. Figliola R, Maione R. MyoD induces the expression of p57Kip2 in cells lacking p21 Cip1/Waf1: Overlapping and distinct functions of the two cdk inhibitors. J Cell Physiol. 2004 ; 200: 468-468
32. Obaya AJ, Sedivy JM. Regulation of cyclin/CDK activity in mammalian cells: a review. Cell Mol Life Sci. 2002 ; 59: 126-126
33. Keenan SM, Lents NH, Baldassare J. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F and G1-S phase progression. J Biol Chem. 2004 ; 7: 5387-5387
34. Reddy RV, Reddy CS. Alteration of EGF levels in developing palate by secalonic acid D. Toxic Mech J. 2005 ; 3: 78-78
35. Soh JW, Weinstein IB. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem. 2003 ; 278: 34709-34709
36. Bamberger AM, Milde-Langosch K, Rössing E, Goemann C, Löning T. Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol. 2001 ; 127: 545-545
37. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 1991 ; 65: 701-701